333 related articles for article (PubMed ID: 34580409)
1. Viral S protein histochemistry reveals few potential SARS-CoV-2 entry sites in human ocular tissues.
Martin G; Wolf J; Lapp T; Agostini HT; Schlunck G; Auw-Hädrich C; Lange CAK
Sci Rep; 2021 Sep; 11(1):19140. PubMed ID: 34580409
[TBL] [Abstract][Full Text] [Related]
2. [A special on epidemic prevention and control: analysis on expression of 2019-nCoV related ACE2 and TMPRSS2 in eye tissues].
Zhang BN; Wang Q; Liu T; Dou SQ; Qi X; Jiang H; Qi BX; Zhang B; Zhou QJ
Zhonghua Yan Ke Za Zhi; 2020 Jun; 56(6):438-446. PubMed ID: 32316719
[TBL] [Abstract][Full Text] [Related]
3. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection.
Zhou L; Xu Z; Castiglione GM; Soiberman US; Eberhart CG; Duh EJ
Ocul Surf; 2020 Oct; 18(4):537-544. PubMed ID: 32544566
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of SARS-CoV-2 entry genes in the superficial adult human conjunctival, limbal and corneal epithelium suggests an additional route of entry via the ocular surface.
Collin J; Queen R; Zerti D; Dorgau B; Georgiou M; Djidrovski I; Hussain R; Coxhead JM; Joseph A; Rooney P; Lisgo S; Figueiredo F; Armstrong L; Lako M
Ocul Surf; 2021 Jan; 19():190-200. PubMed ID: 32502616
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS
J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407
[TBL] [Abstract][Full Text] [Related]
6. Characterization of SARS-CoV-2 Entry Factors' Expression in Corneal and Limbal Tissues of Adult Human Donors Aged from 58 to 85.
Tisi A; Zerti D; Genitti G; Vicentini MT; Baccante M; Flati V; Maccarone R
J Ocul Pharmacol Ther; 2022; 38(1):56-65. PubMed ID: 34889660
[No Abstract] [Full Text] [Related]
7. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea.
Ma D; Chen CB; Jhanji V; Xu C; Yuan XL; Liang JJ; Huang Y; Cen LP; Ng TK
Eye (Lond); 2020 Jul; 34(7):1212-1219. PubMed ID: 32382146
[TBL] [Abstract][Full Text] [Related]
8. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
Roehrich H; Yuan C; Hou JH
Cornea; 2020 Dec; 39(12):1556-1562. PubMed ID: 32826650
[TBL] [Abstract][Full Text] [Related]
10. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
J Genet; 2021; 100(1):. PubMed ID: 33707363
[TBL] [Abstract][Full Text] [Related]
11. Expression of ACE2 and TMPRSS2 Proteins in the Upper and Lower Aerodigestive Tracts of Rats: Implications on COVID 19 Infections.
Sato T; Ueha R; Goto T; Yamauchi A; Kondo K; Yamasoba T
Laryngoscope; 2021 Mar; 131(3):E932-E939. PubMed ID: 32940922
[TBL] [Abstract][Full Text] [Related]
12. Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19.
Muralidar S; Gopal G; Visaga Ambi S
J Med Virol; 2021 Sep; 93(9):5260-5276. PubMed ID: 33851732
[TBL] [Abstract][Full Text] [Related]
13. Comparative analyses of ACE2 and TMPRSS2 gene: Implications for the risk to which vertebrate animals are susceptible to SARS-CoV-2.
Huang C; Jiang Y; Yan J
J Med Virol; 2021 Sep; 93(9):5487-5504. PubMed ID: 33974296
[TBL] [Abstract][Full Text] [Related]
14. Ocular Surface Expression of SARS-CoV-2 Receptors.
Leonardi A; Rosani U; Brun P
Ocul Immunol Inflamm; 2020 Jul; 28(5):735-738. PubMed ID: 32589459
[TBL] [Abstract][Full Text] [Related]
15. Exploration of the ocular surface infection by SARS-CoV-2 and implications for corneal donation: An ex vivo study.
Maurin C; He Z; Mentek M; Verhoeven P; Pillet S; Bourlet T; Rogues F; Pugniet JL; Peyragrosse T; Barallon M; Perrache C; Aouimeur I; Acquart S; Ninotta S; Baud'huin M; Vabres B; Poinard S; Gain P; Thuret G
PLoS Med; 2022 Mar; 19(3):e1003922. PubMed ID: 35231027
[TBL] [Abstract][Full Text] [Related]
16. Expression of the COVID-19 receptor ACE2 in the human conjunctiva.
Lange C; Wolf J; Auw-Haedrich C; Schlecht A; Boneva S; Lapp T; Horres R; Agostini H; Martin G; Reinhard T; Schlunck G
J Med Virol; 2020 Oct; 92(10):2081-2086. PubMed ID: 32374427
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of the SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in human ovaries: Identification of cell types and trends with age.
Wu M; Ma L; Xue L; Zhu Q; Zhou S; Dai J; Yan W; Zhang J; Wang S
Genomics; 2021 Nov; 113(6):3449-3460. PubMed ID: 34418496
[TBL] [Abstract][Full Text] [Related]
18. ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain.
Torre-Fuentes L; Matías-Guiu J; Hernández-Lorenzo L; Montero-Escribano P; Pytel V; Porta-Etessam J; Gómez-Pinedo U; Matías-Guiu JA
J Med Virol; 2021 Feb; 93(2):863-869. PubMed ID: 32691890
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems.
Zhang F; Li W; Feng J; Ramos da Silva S; Ju E; Zhang H; Chang Y; Moore PS; Guo H; Gao SJ
J Med Virol; 2021 Dec; 93(12):6671-6685. PubMed ID: 34324210
[TBL] [Abstract][Full Text] [Related]
20. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein.
Heurich A; Hofmann-Winkler H; Gierer S; Liepold T; Jahn O; Pöhlmann S
J Virol; 2014 Jan; 88(2):1293-307. PubMed ID: 24227843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
